The S100A7 Nuclear Interactors in Autoimmune Diseases: a Coevolutionary Study in Mammals

Overview

Journal Immunogenetics

Specialties Allergy & Immunology
Genetics

Date 2022 Feb 17

PMID 35174412

Authors

Fabio DAmico

Evangelia Skarmoutsou

Massimo Libra

Affiliations

Soon will be listed here.

Abstract

S100A7, a member of the S100A family of Ca-binding proteins, is considered a key effector in immune response. In particular, S100A7 dysregulation has been associated with several diseases, including autoimmune disorders. At the nuclear level, S100A7 interacts with several protein-binding partners which are involved in transcriptional regulation and DNA repair. By using the BioGRID and GAAD databases, S100A7 nuclear interactors with a putative involvement in autoimmune diseases were retrieved. We selected fatty acid-binding protein 5 (FABP5), autoimmune regulator (AIRE), cystic fibrosis transmembrane conductance regulator (CFTR), chromodomain helicase DNA-binding protein 4 (CHD4), epidermal growth factor receptor (EGFR), estrogen receptor 1 (ESR1), histone deacetylase 2 (HDAC2), v-myc avian myelocytomatosis viral oncogene homolog (MYC), protection of telomeres protein 1 (POT1), telomeric repeat-binding factor (NIMA-interacting) 1 (TERF1), telomeric repeat-binding factor 2 (TERF2), and Zic family member 1 (ZIC1). Linear correlation coefficients between interprotein distances were calculated with MirrorTree. Coevolution clusters were also identified with the use of a recent version of the Blocks in Sequences (BIS2) algorithm implemented in the BIS2Analyzer web server. Analysis of pair positions identified interprotein coevolving clusters between S100A7 and the binding partners CFTR and TERF1. Such findings could guide further analysis to better elucidate the function of S100A7 and its binding partners and to design drugs targeting for these molecules in autoimmune diseases.

References

Adler B, Boin F, Wolters P, Bingham C, Shah A, Greider C . Autoantibodies targeting telomere-associated proteins in systemic sclerosis. Ann Rheum Dis. 2021; 80(7):912-919. PMC: 8217217. DOI: 10.1136/annrheumdis-2020-218918. View

Adzhubei I, Schmidt S, Peshkin L, Ramensky V, Gerasimova A, Bork P . A method and server for predicting damaging missense mutations. Nat Methods. 2010; 7(4):248-9. PMC: 2855889. DOI: 10.1038/nmeth0410-248. View

Arnandis T, Ferrer-Vicens I, Torres L, Garcia C, Garcia-Trevijano E, Zaragoza R . Differential functions of calpain 1 during epithelial cell death and adipocyte differentiation in mammary gland involution. Biochem J. 2014; 459(2):355-68. DOI: 10.1042/BJ20130847. View

Austermann J, Spiekermann C, Roth J . S100 proteins in rheumatic diseases. Nat Rev Rheumatol. 2018; 14(9):528-541. DOI: 10.1038/s41584-018-0058-9. View

Brodersen D, Nyborg J, Kjeldgaard M . Zinc-binding site of an S100 protein revealed. Two crystal structures of Ca2+-bound human psoriasin (S100A7) in the Zn2+-loaded and Zn2+-free states. Biochemistry. 1999; 38(6):1695-704. DOI: 10.1021/bi982483d. View

Broome A, Ryan D, Eckert R . S100 protein subcellular localization during epidermal differentiation and psoriasis. J Histochem Cytochem. 2003; 51(5):675-85. PMC: 3785113. DOI: 10.1177/002215540305100513. View

Choi J, Husain M . Calmodulin-mediated cell cycle regulation: new mechanisms for old observations. Cell Cycle. 2006; 5(19):2183-6. DOI: 10.4161/cc.5.19.3265. View

Cury S, Oliveira M, Sibio M, Clara S, Luvizotto R, Conde S . Gene expression of estrogen receptor-alpha in orbital fibroblasts in Graves' ophthalmopathy. Arch Endocrinol Metab. 2015; 59(3):273-6. DOI: 10.1590/2359-3997000000050. View

Da-Silva N, Arasaradnam R, Getliffe K, Sung E, Oo Y, Nwokolo C . Altered mRNA expression of telomere binding proteins (TPP1, POT1, RAP1, TRF1 and TRF2) in ulcerative colitis and Crohn's disease. Dig Liver Dis. 2010; 42(8):544-8. DOI: 10.1016/j.dld.2009.12.005. View

10.

de Juan D, Pazos F, Valencia A . Emerging methods in protein co-evolution. Nat Rev Genet. 2013; 14(4):249-61. DOI: 10.1038/nrg3414. View

11.

Dib L, Carbone A . CLAG: an unsupervised non hierarchical clustering algorithm handling biological data. BMC Bioinformatics. 2012; 13:194. PMC: 3519615. DOI: 10.1186/1471-2105-13-194. View

12.

Edgar R . MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004; 32(5):1792-7. PMC: 390337. DOI: 10.1093/nar/gkh340. View

13.

Fairall L, CHAPMAN L, Moss H, de Lange T, Rhodes D . Structure of the TRFH dimerization domain of the human telomeric proteins TRF1 and TRF2. Mol Cell. 2001; 8(2):351-61. DOI: 10.1016/s1097-2765(01)00321-5. View

14.

Felice C, Lewis A, Armuzzi A, Lindsay J, Silver A . Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases. Aliment Pharmacol Ther. 2014; 41(1):26-38. DOI: 10.1111/apt.13008. View

15.

Feng Z, Zhang S, Wen H, Liang Y . Association of rs2075876 polymorphism of AIRE gene with rheumatoid arthritis risk. Hum Immunol. 2015; 76(4):281-5. DOI: 10.1016/j.humimm.2015.01.026. View

16.

Ferrera F, Rizzi M, Sprecacenere B, Balestra P, Sessarego M, Di Carlo A . AIRE gene polymorphisms in systemic sclerosis associated with autoimmune thyroiditis. Clin Immunol. 2006; 122(1):13-7. DOI: 10.1016/j.clim.2006.09.013. View

17.

Foell D, Roth J . Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum. 2004; 50(12):3762-71. DOI: 10.1002/art.20631. View

18.

Georgin-Lavialle S, Aouba A, Mouthon L, Londono-Vallejo J, Lepelletier Y, Gabet A . The telomere/telomerase system in autoimmune and systemic immune-mediated diseases. Autoimmun Rev. 2010; 9(10):646-51. DOI: 10.1016/j.autrev.2010.04.004. View

19.

Gerasimenko O, Gerasimenko J . New aspects of nuclear calcium signalling. J Cell Sci. 2004; 117(Pt 15):3087-94. DOI: 10.1242/jcs.01295. View

20.

Glaser R, Meyer-Hoffert U, Harder J, Cordes J, Wittersheim M, Kobliakova J . The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption. J Invest Dermatol. 2008; 129(3):641-9. DOI: 10.1038/jid.2008.268. View